Solid Biosciences SLDB
NASDAQ SLDB
$6.91 -0.07 (-1.07%)
As of: Oct 2, 2026 · 12:51 PM EDT

Solid Biosciences (SLDB) Depreciation & Amortization (CF) (2017 - 2026)

Updated

Solid Biosciences (SLDB) recorded Depreciation & Amortization (CF) of $391,000 in Q2 2026, up 1.3% from $386,000 a year earlier but down 1.0% from the prior quarter.

Analysis

Solid Biosciences (SLDB) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

On a TTM basis, Solid Biosciences' Depreciation & Amortization (CF) came in at $1.63 million as of Jun 30, 2026, down 3.4% year-over-year; for FY2025, it came in at $1.64 million, down 33.4% from FY2024.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $2.46 million in FY2024 (-4.9%), $2.58 million in FY2023 (+7.2%), $2.41 million in FY2022 (-18.8%) and $2.96 million in FY2021 (-24.4%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $327,000 in Q1 2024 to $1.24 million in Q2 2024 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) rose in two of the last eight quarters, with an average decline of 13.2%.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 75.7% in Q2 2024, against a decline of 68.7% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $395,000 (Q1 2026), $467,000 (Q4 2025) and $376,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Solid Biosciences 1.04 Bn 1.04 Bn - 391,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 391,000.00
Mar 31, 2026 395,000.00
Dec 31, 2025 467,000.00
Sep 30, 2025 376,000.00
Jun 30, 2025 386,000.00
Mar 31, 2025 407,000.00
Dec 31, 2024 488,000.00
Sep 30, 2024 405,000.00
Jun 30, 2024 1.24 Mn
Mar 31, 2024 327,000.00
Dec 31, 2023 587,000.00
Sep 30, 2023 588,000.00
Jun 30, 2023 703,000.00
Mar 31, 2023 703,000.00
Dec 31, 2022 539,000.00
Sep 30, 2022 438,000.00
Jun 30, 2022 722,000.00
Mar 31, 2022 709,000.00
Dec 31, 2021 760,000.00
Sep 30, 2021 752,000.00
API Access

Solid Biosciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SLDB&period=max&api_key=YOUR_API_KEY